Is hematopoietic cell transplantation still a valid option for mantle cell lymphoma in first remission in the chemoimmunotherapy-era?
To transplant or not: a dilemma for treatment of elderly AML patients in the twenty-first century
Towards a global system of vigilance and surveillance in unrelated donors of haematopoietic progenitor cells for transplantation
Translating the HLA-DPB1 T-cell epitope-matching algorithm into clinical practice
Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation : This article has been corrected since Advance Online Publication and an erratum is also printed in this issue.
Long-term outcomes of unmanipulated haploidentical HSCT for paediatric patients with acute leukaemia
The impact of morphological and immunohistological changes in minor salivary glands on the health of the oral cavity in HSCT patients
Pre-transplant FDG-PET-based survival model in relapsed and refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and auto-SCT
Modified high-dose melphalan and autologous SCT for AL amyloidosis or high-risk myeloma: analysis of SWOG trial S0115
Long-term outcome of patients with mutiple myeloma-related advanced renal failure following auto-SCT
Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unit
Outcomes of hematopoietic SCT recipients with rhinovirus infection: a matched, case-control study
Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation
Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA?
Active thrombopoiesis is associated with worse severity and activity of chronic GVHD
Nailfold capillary abnormalities in sclerodermatous chronic GVHD
Long-term follow-up of a prospective randomized trial comparing CYA and MTX with CYA and mycophenolate mofetil for GVHD prophylaxis in myeloablative sibling donor hematopoietic cell transplantation
‘Yet another rose’
In situ chimerism after double cord blood transplantation
Pre-engraftment blood stream infection is a risk factor for acute GVHD grades II-IV
Successful management of Candida krusei monoarthritis after allo-SCT
Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation
In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study